Stéphanie Beauchemin
- Co-authors
- Vincent PichetteAgnès LeblondJudith NaudJosée MichaudStéphane LefrançoisMarie‐Josée HébertMichel RogerLouis‐Philippe Laurin
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)SARS-CoV-2 detection and testing (4 papers)Pharmacological Effects and Toxicity Studies (3 papers)
- Partner nations
- CanadaUnited States
In The Last Decade
Stéphanie Beauchemin
12 papers receiving 201 citations
Peers
Comparison fields: 5 of 64
- Oncology 65
- Pediatrics, Perinatology and Child Health 58
- Infectious Diseases 51
- Nephrology 38
- Molecular Biology 36
Countries citing papers authored by Stéphanie Beauchemin
This map shows the geographic impact of Stéphanie Beauchemin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Beauchemin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Beauchemin more than expected).
Fields of papers citing papers by Stéphanie Beauchemin
This network shows the impact of papers produced by Stéphanie Beauchemin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Beauchemin. The network helps show where Stéphanie Beauchemin may publish in the future.
Co-authorship network of co-authors of Stéphanie Beauchemin
This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Beauchemin. A scholar is included among the top collaborators of Stéphanie Beauchemin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Beauchemin. Stéphanie Beauchemin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 19 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 8 | |
| 8 | 6 | |
| 9 | 14 | |
| 10 | 7 | |
| 11 | 101 | |
| 12 | 28 | |
| 13 | 1 |
About Stéphanie Beauchemin
Stéphanie Beauchemin is a scholar working on Infectious Diseases, Nephrology and Pharmacology, having authored 13 papers that have together received 208 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Nephrology (38 citations), Pharmacology (29 citations) and Transplantation (8 citations). Stéphanie Beauchemin has collaborated with scholars based in Canada and United States. Frequent co-authors include Vincent Pichette, Agnès Leblond, Judith Naud, Josée Michaud, Stéphane Lefrançois, Marie‐Josée Hébert, Michel Roger, Louis‐Philippe Laurin, Claire Nour Abou Chakra and Daniela Ziegler. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.